Carbon Dots in Treatment of Pediatric Brain Tumors: Past, Present, and Future Directions

Pediatric brain tumors remain a significant source of morbidity and mortality. Though developments have been made in treating these malignancies, the blood–brain barrier, intra- and inter-tumoral heterogeneity, and therapeutic toxicity pose challenges to improving outcomes. Varying types of nanopart...

Full description

Bibliographic Details
Main Authors: Frederic A. Vallejo, Ganesh Sigdel, Eduardo A. Veliz, Roger M. Leblanc, Steven Vanni, Regina M. Graham
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/11/9562
_version_ 1797597445276827648
author Frederic A. Vallejo
Ganesh Sigdel
Eduardo A. Veliz
Roger M. Leblanc
Steven Vanni
Regina M. Graham
author_facet Frederic A. Vallejo
Ganesh Sigdel
Eduardo A. Veliz
Roger M. Leblanc
Steven Vanni
Regina M. Graham
author_sort Frederic A. Vallejo
collection DOAJ
description Pediatric brain tumors remain a significant source of morbidity and mortality. Though developments have been made in treating these malignancies, the blood–brain barrier, intra- and inter-tumoral heterogeneity, and therapeutic toxicity pose challenges to improving outcomes. Varying types of nanoparticles, including metallic, organic, and micellar molecules of varying structures and compositions, have been investigated as a potential therapy to circumvent some of these inherent challenges. Carbon dots (CDs) have recently gained popularity as a novel nanoparticle with theranostic properties. This carbon-based modality is highly modifiable, allowing for conjugation to drugs, as well as tumor-specific ligands in an effort to more effectively target cancerous cells and reduce peripheral toxicity. CDs are being studied pre-clinically. The ClinicalTrials.gov site was queried using the search terms: brain tumor and nanoparticle, liposome, micelle, dendrimer, quantum dot, or carbon dot. At the time of this review, 36 studies were found, 6 of which included pediatric patients. Two of the six studies investigated nanoparticle drug formulations, whereas the other four studies were on varying liposomal nanoparticle formulations for the treatment of pediatric brain tumors. Here, we reviewed the context of CDs within the broader realm of nanoparticles, their development, promising pre-clinical potential, and proposed future translational utility.
first_indexed 2024-03-11T03:05:12Z
format Article
id doaj.art-efd0ee1a1dd54ee382a5d67cbf803d52
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T03:05:12Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-efd0ee1a1dd54ee382a5d67cbf803d522023-11-18T08:00:47ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-05-012411956210.3390/ijms24119562Carbon Dots in Treatment of Pediatric Brain Tumors: Past, Present, and Future DirectionsFrederic A. Vallejo0Ganesh Sigdel1Eduardo A. Veliz2Roger M. Leblanc3Steven Vanni4Regina M. Graham5Department of Neurosurgery, Miller School of Medicine, University of Miami, 1095 NW 14th Terrace, Miami, FL 33136, USADepartment of Chemistry, University of Miami, 1301 Memorial Drive, Coral Gables, FL 33146, USADepartment of Chemistry, University of Miami, 1301 Memorial Drive, Coral Gables, FL 33146, USADepartment of Chemistry, University of Miami, 1301 Memorial Drive, Coral Gables, FL 33146, USADepartment of Neurosurgery, Miller School of Medicine, University of Miami, 1095 NW 14th Terrace, Miami, FL 33136, USADepartment of Neurosurgery, Miller School of Medicine, University of Miami, 1095 NW 14th Terrace, Miami, FL 33136, USAPediatric brain tumors remain a significant source of morbidity and mortality. Though developments have been made in treating these malignancies, the blood–brain barrier, intra- and inter-tumoral heterogeneity, and therapeutic toxicity pose challenges to improving outcomes. Varying types of nanoparticles, including metallic, organic, and micellar molecules of varying structures and compositions, have been investigated as a potential therapy to circumvent some of these inherent challenges. Carbon dots (CDs) have recently gained popularity as a novel nanoparticle with theranostic properties. This carbon-based modality is highly modifiable, allowing for conjugation to drugs, as well as tumor-specific ligands in an effort to more effectively target cancerous cells and reduce peripheral toxicity. CDs are being studied pre-clinically. The ClinicalTrials.gov site was queried using the search terms: brain tumor and nanoparticle, liposome, micelle, dendrimer, quantum dot, or carbon dot. At the time of this review, 36 studies were found, 6 of which included pediatric patients. Two of the six studies investigated nanoparticle drug formulations, whereas the other four studies were on varying liposomal nanoparticle formulations for the treatment of pediatric brain tumors. Here, we reviewed the context of CDs within the broader realm of nanoparticles, their development, promising pre-clinical potential, and proposed future translational utility.https://www.mdpi.com/1422-0067/24/11/9562pediatric brain tumorprecision medicinenanoparticlenanomedicinecancercarbon dot
spellingShingle Frederic A. Vallejo
Ganesh Sigdel
Eduardo A. Veliz
Roger M. Leblanc
Steven Vanni
Regina M. Graham
Carbon Dots in Treatment of Pediatric Brain Tumors: Past, Present, and Future Directions
International Journal of Molecular Sciences
pediatric brain tumor
precision medicine
nanoparticle
nanomedicine
cancer
carbon dot
title Carbon Dots in Treatment of Pediatric Brain Tumors: Past, Present, and Future Directions
title_full Carbon Dots in Treatment of Pediatric Brain Tumors: Past, Present, and Future Directions
title_fullStr Carbon Dots in Treatment of Pediatric Brain Tumors: Past, Present, and Future Directions
title_full_unstemmed Carbon Dots in Treatment of Pediatric Brain Tumors: Past, Present, and Future Directions
title_short Carbon Dots in Treatment of Pediatric Brain Tumors: Past, Present, and Future Directions
title_sort carbon dots in treatment of pediatric brain tumors past present and future directions
topic pediatric brain tumor
precision medicine
nanoparticle
nanomedicine
cancer
carbon dot
url https://www.mdpi.com/1422-0067/24/11/9562
work_keys_str_mv AT fredericavallejo carbondotsintreatmentofpediatricbraintumorspastpresentandfuturedirections
AT ganeshsigdel carbondotsintreatmentofpediatricbraintumorspastpresentandfuturedirections
AT eduardoaveliz carbondotsintreatmentofpediatricbraintumorspastpresentandfuturedirections
AT rogermleblanc carbondotsintreatmentofpediatricbraintumorspastpresentandfuturedirections
AT stevenvanni carbondotsintreatmentofpediatricbraintumorspastpresentandfuturedirections
AT reginamgraham carbondotsintreatmentofpediatricbraintumorspastpresentandfuturedirections